“opioids” Archives

in
Entry Author Date Location
FDA Again Dings Heron’s Opioid Alternative Over “Nonclinical Issues” 06/29/20 San Diego
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
Two Big Pharma Alliances End in Nixed Deals. Here’s What Happened. 02/11/20 National
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More 10/18/19 National
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
Boston Tech Watch: DraftKings Drives, The Engine Revs, NuTonomy Swaps 08/30/19 Boston
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More 05/31/19 National
Alnylam Makes Case For 2nd RNAi Drug at Big Liver Disease Meeting 04/12/19 Boston
Sobriety Pays: DynamiCare Gamifies Staying Clean for Recovering Addicts 04/09/19 Boston
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
FDA Rejects Alkermes Depression Drug, Asks for More Clinical Data 02/01/19 Boston
Pear Therapeutics App Gets FDA Nod for Treating Opioid Abuse 12/11/18 Boston
FDA Blasts Data, Trial Design For Alkermes Depression Drug 10/30/18 Boston
Centrexion Plans IPO to Bankroll Non-Opioid Pain Drugs 10/22/18 Boston
Adynxx Agrees to Merger with Alliqua to Gain Public Stock Listing 10/12/18 San Francisco
NIH Outlines $500M Plan to Develop New Pain Drugs and Fight Opioid Crisis 06/13/18 National
Xconomy Roadmap 2018: Top 15 Innovation Areas to Watch 04/09/18 National
At Opioid Hearing, BIO Exec Proposes Ways to Boost Pain Drug Development 03/21/18 National
Bio Roundup: Meldonium Slip, Kratom Crackdown, Zinc Fingers & More 02/23/18 National
As Trump Budget Addresses Opioid Crisis, BIO Report Reveals Scarce Pain Drug Development 02/12/18 National
After Strong 2017, Biotechs & Medtechs Start ’18 with Venture, IPO News 01/02/18 National
Bio Roundup: Tax Cuts, Drug Approval Record, New Flagship Cash & More 12/22/17 National
Few Opioid Alternatives In Sight as Crisis Gains Political Attention 11/01/17 National
No Pain, No High: Nektar’s Opioid Drug Hits Trial Goals, Lifts Shares 03/20/17 San Francisco
Tour of Texas: Technium, Vapogenix, StemBioSys, & OneTeam Collective 12/12/16 Texas
Regeneron, in Pain Drug Race With Pfizer & Lilly, Gets $250M From Teva 09/20/16 New York
How to Make Healthcare Better? Make It Easy 06/08/16 Boston
Dear Biopharma: Give Us Better Therapies for Pain 03/23/16 Boston
In Move That Spells Relief, Zogenix Sells Painkiller to Pernix 03/10/15 San Diego
Page 1 of 2 next page »